
- Applied Clinical Trials-07-01-2008
- Volume 0
- Issue 0
Update on Russia Trials
A recently released report details the current status of the clinical trials market in Russia.
A recently released report details the current status of the clinical trials market in Russia. According to the Russian CRO Synergy Research Group, the Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 130 new clinical trials in Russia in first quarter 2008; that's four trials less than in the corresponding period last year.
The report noted that the main contribution is still made by multinational, multicenter clinical trials. The share of foreign study sponsors in first quarter 2008 stood at 68% of the total number of clinical trials, and 88 new trials were initiated during this period. To read the report from Synergy Research Group, go to
Articles in this issue
over 17 years ago
Business and People Update July 2008over 17 years ago
July Global Newsover 17 years ago
Where's the Trial Dataover 17 years ago
A Dow Jones for Sitesover 17 years ago
ICREL Assesses EU Trials Directiveover 17 years ago
Remembering Recruitmentover 17 years ago
Joint Lab Venture Targets Chinaover 17 years ago
Benchmarking Sitesover 17 years ago
Metrics Gain Tractionover 17 years ago
Orphan Drug R&D Challenges SponsorsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.